Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

NCT01919086

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details
Completed

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

NCT02833610

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts general Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
View Trial Details
Completed

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

NCT05561751

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • University of Florida (UF) - Shands Cancer Center Gainesville, Florida, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

NCT05014412

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
  • Cancer Care & Hematology - Fort Collins Fort Collins, Colorado, United States
View all 50 locations
View Trial Details

Related conditions